Canada’s Innovation and Skills Plan, led by Innovation, Science and Economic Development Canada, with respect to ensuring that the life sciences sector is a major focus of the government’s post-COVID recovery plan
Engagement with federal officials regarding Health Canada’s plans for the creation of a national strategy for rare diseases, national pharmacare and the Canada Drug Agency
Engagement with federal officials regarding Innovation, Science and Economic Development Canada’s plans for the creation of new biomanufacturing capacity for Canada
Engagement with officials regarding access and approval of mental health treatments and drugs.
Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries.
Innovation, Science and Economic Development Canada and Innovation Agenda, Science and Technology Strategy, or other Government policy or program initiatives to support research and development activities in Canada.
Policies or Program, Regulation
Guidelines, policies and programs related to regulatory and reporting functions of the Patented Medicine Prices Review Board
